Efficacy of a Dose-Intensified CHOP (Double-CHOP) Regimen for Peripheral T-Cell Lymphomas

被引：0

作者：

Takahashi, Hiromichi ^{[1
]}

Iriyama, Noriyoshi ^{[1
]}

Hatta, Yoshihiro ^{[1
]}

Miura, Katsuhiro ^{[1
]}

Kobayashi, Yujin ^{[1
]}

Kurita, Daisuke ^{[1
]}

Hirabayashi, Yukio ^{[1
]}

Hojo, Atsuko ^{[1
]}

Kodaira, Hitomi ^{[1
]}

Yagi, Mai ^{[1
]}

Kiso, Satomi ^{[1
]}

Uchino, Yoshihito ^{[1
]}

Nakagawa, Masaru ^{[1
]}

Kusuda, Machiko ^{[1
]}

Kobayashi, Sumiko ^{[1
]}

Horikoshi, Akira ^{[1
]}

Kura, Yoshimasa ^{[2
]}

Yamazaki, Tetsuo ^{[1
]}

Sawada, Umihiko ^{[2
]}

Takeuchi, Jin ^{[1
]}

机构：

[1] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo, Japan

[2] Kasukabe Municipal Hosp, Div Hematol & Oncol, Saitama, Japan

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.4855.4855

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4855

引用

页数：1

共 50 条

[21] Beyond CHOP: optimising frontline therapy in peripheral T-cell lymphoma
Amin, Faisal
Gleeson, Mary
ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (07) : 2548 - 2552
[22] Early Results of a Phase Ib/II Dose-Escalation Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphomas (PTCL)
Dupuis, Jehan
Casasnovas, Rene-Olivier
Morschhauser, Franck
Ghesquieres, Herve
Thieblemont, Catherine
Ribrag, Vincent
Tilly, Herve
Coiffier, B.
BLOOD, 2011, 118 (21) : 1148 - 1148
[23] Dose-intensified treatment of diffuse large B-cell lymphomas
Zwick, Carsten
Held, Gerhard
Pfreundschuh, Michael
EJC SUPPLEMENTS, 2008, 6 (02): : 24 - 30
[24] Comparison of Efficacy and Safety of Gdpt and CHOP in First-Line Treatment of Peripheral T-Cell Lymphoma
Zhao, Kangjin
Zhang, Mingzhi
BLOOD, 2024, 144
[25] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
Jong Gwang Kim
Sang Kyun Sohn
Yee Soo Chae
Yoon Young Cho
Deok Hwan Yang
Je-Jung Lee
Hyeoung-Joon Kim
Ho Jin Shin
Joo Seop Chung
Goon Jae Cho
Won-Sik Lee
Young-Don Joo
Chang-Hak Sohn
Suk Joong Oh
Cancer Chemotherapy and Pharmacology, 2007, 60 : 129 - 134
[26] Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas
Jia, Bo
Hu, Shaoxuan
Yang, Jianliang
Zhou, Shengyu
Liu, Peng
Qin, Yan
Gui, Lin
Yang, Sheng
Lin, Hua
Zhang, Changgong
Xing, Puyuan
Wang, Lin
Dong, Mei
Zhou, Liqiang
Sun, Yan
He, Xiaohui
Shi, Yuankai
HEMATOLOGY, 2016, 21 (09) : 536 - 541
[27] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
Kim, Jong Gwang
Sohn, Sang Kyun
Chae, Yee Soo
Cho, Yoon Young
Yang, Deok Hwan
Lee, Je-Jung
Kim, Hyeoung-Joon
Shin, Ho Jin
Chung, Joo Seop
Cho, Goon Jae
Lee, Won-Sik
Joo, Young-Don
Sohn, Chang-Hak
Oh, Suk Joong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 129 - 134
[28] A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas
Liu, Xuyan
Yang, Mingzi
Wu, Meng
Zheng, Wen
Xie, Yan
Zhu, Jun
Song, Yuqin
Liu, Weiping
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 443 - 449
[29] A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas
Xuyan Liu
Mingzi Yang
Meng Wu
Wen Zheng
Yan Xie
Jun Zhu
Yuqin Song
Weiping Liu
Cancer Chemotherapy and Pharmacology, 2019, 83 : 443 - 449
[30] Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP
Wilcox, Ryan A.
LANCET HAEMATOLOGY, 2018, 5 (05): : E182 - E183

← 1 2 3 4 5 →